✦ LIBER ✦
Loss of the E3 Ubiquitin Ligase CBL Confers Chemoresistance in Human Pancreatic Cancer and is Targeted by Epidermal Growth Factor Receptor Inhibition
✍ Scribed by Kadera, B.E.; Toste, P.A.; Wu, N.; Li, L.; Dawson, D.W.; Donahue, T.R.
- Book ID
- 122195393
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 287 KB
- Volume
- 186
- Category
- Article
- ISSN
- 0022-4804
No coin nor oath required. For personal study only.